Figure 3.
Figure 3. Frequency of CMV-specific T cells in vivo. (A) Frequency of CMVSTs in the peripheral blood before (pre) infusion and after (post) infusion, as measured by using the IFN-γ ELISPOT assay after overnight stimulation with IE1 and pp65 viral PepMixes. Results are expressed as SFCs per 5 × 105 input cells (mean ± SEM, n = 10). (B) Persistence of infused CMVSTs in individual patients. Frequency of T cells in peripheral blood as measured by using the IFN-γ ELISPOT assay after stimulation with epitope-specific CMV peptides with restriction to HLA antigens exclusive to the CMVST line or shared between the recipient and the CMVST line.

Frequency of CMV-specific T cells in vivo. (A) Frequency of CMVSTs in the peripheral blood before (pre) infusion and after (post) infusion, as measured by using the IFN-γ ELISPOT assay after overnight stimulation with IE1 and pp65 viral PepMixes. Results are expressed as SFCs per 5 × 105 input cells (mean ± SEM, n = 10). (B) Persistence of infused CMVSTs in individual patients. Frequency of T cells in peripheral blood as measured by using the IFN-γ ELISPOT assay after stimulation with epitope-specific CMV peptides with restriction to HLA antigens exclusive to the CMVST line or shared between the recipient and the CMVST line.

Close Modal

or Create an Account

Close Modal
Close Modal